
Peptomyc
Developer of cell-penetrating mini-protein therapeutics designed to treat cancer. The company's therapeutics target the Myc oncogene, a central function in cancer cell survival, that lets cancer cells...
Valuation
$0
Share Price
N/A
Total Raised
$19.1M
Last Round
N/A